Wegovy safety and effectiveness study in Korea
Treatments studied
Part of Hormones & metabolism clinical trials.
This study watches how Wegovy (semaglutide) works and its side effects when given by doctors to patients with obesity or overweight in South Korea. It is not testing a new drug, but collecting information from routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult aged 19 or older.
- You have obesity or are overweight and your doctor has decided to prescribe Wegovy for you.
- You have not taken Wegovy or any semaglutide medicine before.
- You are not allergic to semaglutide or any of its ingredients.
- If you could become pregnant, you are using effective birth control and are not pregnant or breastfeeding.
- You are able to understand and cooperate with the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether semaglutide (a weight-loss medication) works differently in people with varying degrees of insulin resistance (how well your body uses sugar). If you are obese without diabetes, you may be able to join.
This study tracks how well Wegovy (a once-weekly injection for weight loss) works for people in Korea who are just starting the medication. It helps doctors understand real-world results outside of a research clinic.
This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.
This study observes how Wegovy works in everyday medical practice for people who are starting it for the first time. It will help doctors learn more about its real-life benefits and safety.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This trial compares a semaglutide injection to the already-approved weight loss drug Wegovy in Chinese adults with obesity. It aims to see if the new option works just as well to help people lose weight.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.